EUCTR2015-002972-26-DK进行中（未招募）1 期
ow dose naltrexone for treatment of pain in patients with fibromyalgia - effect via central mechanism?A randomized, double-blinded, placebo-controlled, cross-over study - Low dose naltrexone
Smerteklinikken0 个研究点目标入组 70 人开始时间: 2015年10月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- > 18 years
- •- Fibromyalgi
- •- Patient in one of the involved pain centre in the study
- •- No inflammatory rheumatic pain condition
- •- Women - treatment with contrceptiva if not menopausal
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Treatment with opioids (other stable analgesic treatment 14 days before study start is allowed
- •- No change in stable analgesic treatment (p.n. paracetamol is allowed)
- •- Pregnant/breatfeeding
- •- Don´t speak danish
- •- Allergic to ingredient
研究者
相似试验
招募中
不适用
ow Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Diseasethat failed conventional treatmentNL-OMON21939ZonMW122
尚未招募
2 期
ow Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn*s Disease that failed conventional treatmentinflammatory bowel disease10017969Crohn's diseaseNL-OMON52463Erasmus MC, Universitair Medisch Centrum Rotterdam122
已完成
4 期
Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?FibromyalgiaNCT02806440Rigshospitalet, Denmark58
招募中
1 期
ow Dose Naltrexone for the treatment of long COVID-19long COVIDPost COVID-19 ConditionPost-acute sequelae of COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12623001042639Griffith University56
尚未招募
1 期
low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptomsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Long COVIDOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)Infection - Other infectious diseasesNeurological - Other neurological disordersRespiratory - Other respiratory disorders / diseasesACTRN12624001162505Griffith University56